期刊文献+

液相色谱-串联质谱法测定人血浆中泮托拉唑的浓度 被引量:1

LC-MS/MS determination of pantoprazole content in human plasma
原文传递
导出
摘要 目的:建立LC-MS/MS法测定人血浆中泮托拉唑的浓度。方法:人血浆样本以乙腈沉淀蛋白后,选用Zorbax SB-C18Narrow-Bore色谱柱(150 mm×2.1 mm,5μm),以甲醇-10 mmol.L-1乙酸铵(65∶35)为流动相,流速为0.40 mL.min-1;选用API3200型三重四极杆串联质谱仪的多重反应监测(MRM)扫描方式进行监测,电喷雾离子化源,正离子方式,选择监测离子反应分别为m/z 384.1→m/z 200.2(泮托拉唑)和m/z 370.1→m/z 252.0(内标兰索拉唑)。结果:泮托拉唑和兰索拉唑的保留时间分别为1.75 min和2.36 min;血浆中泮托拉唑的线性范围为0.0100~6.00 mg.L-1(r>0.99),定量下限为0.0100 mg.L-1;日内、日间相对标准差(RSD)均小于5%;相对偏差(RE)均在±4%的范围以内;平均提取回收率为(97.2±5.4)%;稳定性试验中,在各种贮存条件下血浆中泮托拉唑均较稳定。结论:该方法快速、灵敏、准确、专属性强、重现性好,适用于人血浆中泮托拉唑浓度的测定,可应用于泮托拉唑钠肠溶片的人体生物等效性研究。 Objective:To develop an LC-MS/MS method for determination of pantoprazole in human plasma.Methods:After protein precipitation with acetonitrile,the analyte and internal standard,lansoprazole,were separated on a Zorbax SB-C18 Narrow-Bore analytical column(150 mm×2.1 mm,5 μm) with the mobile phase of methanol and 10 mmol·L-1 ammonium acetate(65∶ 35) at a flow rate of 0.40 mL·min-1.Detection was carried out by electrospray positive ionization mass spectrometry in the multiple reaction monitoring(MRM) mode.The MRM transitions of m/z 384.1→m/z 200.2 and m/z 370.1→m/z 252.0 were used to quantify pantoprazole and IS,respectively.Results:Pantoprazole and internal standard were eluted at 1.75 and 2.36 min,respectively.The calibration curve was linear over the concentration range of 0.0100-6.00 mg·L-1 with the lower limit of quantitation(LLOQ) 0.0100 mg·L-1.Intra-day and inter-day relative standard deviations were both less than 5%,and the relative errors were within±4%.The mean extract recoveries were(97.2±5.4)%.In the stability studies,pantoprazole in plasma was found to be stable under various storage conditions.Conclusion:It is a rapid,sensitive,selective and reliable method for the determination of pantoprazole in human plasma.The method was successfully applied to a bioequivalence study of pantoprazole sodium enteric-coated tablet in healthy volunteers.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第12期2284-2288,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 泮托拉唑 人血浆 液相色谱-串联质谱联用法 生物等效性 个体间差异 pantoprazole human plasma LC-MS/MS bioequivalence inter-individual differences
  • 相关文献

参考文献24

  • 1Simon WA, Keeling DJ, Laing SM, et al. Biochemistry of a novel (H^+ + K+ ) - ATPase inhibitor. Biochem Pharmacol, 1990, 39 (11) :1799.
  • 2Horn J. The proton - pump inhibitors : similarities and differences. Clin Ther,2000,22 ( 3 ) :266.
  • 3Jungnickel PW. Pantoprazole:A new proton pump inhibitor. Clin T- her,2000,22 ( 11 ) : 1268.
  • 4Zarghi A, Shafaati A, Foroutan SM ,et al. A rapid high - performance liquid chromatographic method for the determination of pantoprazole in plasma using UV detection. Arzneimittelforschung ,2008 ,58 (9) : 441.
  • 5Kocyigit - Kaymakcoglu B, Unsalan S, Rollas S. Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography. Pharmazie, 2006,61 (7) :586.
  • 6Noubarani M, Keyhanfar F, Motevalian M, et al. Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma. J Pharm Sci,2010,13 (1):1.
  • 7焦效兰,段京莉,司凯英,黄小芳,刘东麟,严宝霞.高效液相色谱法测定血浆中泮托拉唑浓度[J].中国药学杂志,1999,34(7):483-485. 被引量:9
  • 8肇丽梅,菅凌燕,段旭.泮托拉唑肠溶片药动学及相对生物利用度[J].中国药学杂志,2000,35(5):329-331. 被引量:10
  • 9周学敏,刘杰,高娟,许荔新,姜利民,李凤才.泮托拉唑钠肠溶微丸胶囊人体生物等效性研究[J].中国新药杂志,2006,15(12):1008-1010. 被引量:5
  • 10曹继军.泮托拉唑钠肠溶胶囊在健康人体的药动学和生物等效性[J].中国药学杂志,2008,43(8):617-620. 被引量:10

二级参考文献37

共引文献31

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部